TickerFactsScreenerDevelopers

Monopar Therapeutics (MNPR) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2015: $2.75M2016: $2.83M2017: $9.62M2018: $6.92M2019: $12.63M2020: $15.69M2021: $18.94M2022: $10.09M2023: $5.59M2024: $55.04M2025: $137.83M$137.83M
2015Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$137.83M+150.4%
2024$55.04M+885.0%
2023$5.59M-44.6%
2022$10.09M-46.7%
2021$18.94M+20.7%
2020$15.69M+24.3%
2019$12.63M+82.5%
2018$6.92M-28.1%
2017$9.62M+239.8%
2016$2.83M+2.8%
2015$2.75M—